Cvs Health Corp Stock Net Income
| CVS Stock | USD 59.85 0.11 0.18% |
CVS Health Corp fundamentals help investors to digest information that contributes to CVS Health's financial success or failures. It also enables traders to predict the movement of CVS Stock. The fundamental analysis module provides a way to measure CVS Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CVS Health stock.
| Last Reported | Projected for Next Year | ||
| Net Income | 8.3 B | 8.8 B | |
| Net Income Applicable To Common Shares | 4.8 B | 3.7 B | |
| Net Income From Continuing Ops | 8.4 B | 5.5 B | |
| Net Income Per Share | 6.49 | 6.82 | |
| Net Income Per E B T | 0.75 | 0.46 |
CVS | Net Income |
CVS Health Corp Company Net Income Analysis
CVS Health's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current CVS Health Net Income | 8.34 B |
Most of CVS Health's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CVS Health Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
CVS Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for CVS Health is extremely important. It helps to project a fair market value of CVS Stock properly, considering its historical fundamentals such as Net Income. Since CVS Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CVS Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CVS Health's interrelated accounts and indicators.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
CVS Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, CVS Health Corp reported net income of 8.34 B. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The net income for all United States stocks is significantly lower than that of the firm.
CVS Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CVS Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CVS Health could also be used in its relative valuation, which is a method of valuing CVS Health by comparing valuation metrics of similar companies.CVS Health is currently under evaluation in net income category among its peers.
CVS Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, CVS Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to CVS Health's managers, analysts, and investors.Environmental | Governance | Social |
CVS Health Institutional Holders
Institutional Holdings refers to the ownership stake in CVS Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of CVS Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing CVS Health's value.| Shares | Jpmorgan Chase & Co | 2024-06-30 | 13.9 M | Pzena Investment Management, Llc | 2024-09-30 | 13.1 M | Franklin Resources Inc | 2024-09-30 | 12.9 M | Charles Schwab Investment Management Inc | 2024-09-30 | 12.2 M | Amvescap Plc. | 2024-06-30 | 12.1 M | Glenview Capital Management Llc | 2024-09-30 | 11.9 M | Hotchkis & Wiley Capital Management Llc | 2024-09-30 | 11.9 M | Northern Trust Corp | 2024-09-30 | 11.6 M | Legal & General Group Plc | 2024-06-30 | 11.4 M | Vanguard Group Inc | 2024-09-30 | 117.6 M | Blackrock Inc | 2024-06-30 | 100.2 M |
CVS Fundamentals
| Return On Equity | 0.067 | ||||
| Return On Asset | 0.0237 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 148.48 B | ||||
| Shares Outstanding | 1.26 B | ||||
| Shares Owned By Insiders | 0.11 % | ||||
| Shares Owned By Institutions | 82.91 % | ||||
| Number Of Shares Shorted | 21.85 M | ||||
| Price To Earning | 42.99 X | ||||
| Price To Book | 1.01 X | ||||
| Price To Sales | 0.21 X | ||||
| Revenue | 357.78 B | ||||
| Gross Profit | 53.46 B | ||||
| EBITDA | 13.74 B | ||||
| Net Income | 8.34 B | ||||
| Cash And Equivalents | 12.95 B | ||||
| Cash Per Share | 15.21 X | ||||
| Total Debt | 79.39 B | ||||
| Debt To Equity | 1.00 % | ||||
| Current Ratio | 0.94 X | ||||
| Book Value Per Share | 59.57 X | ||||
| Cash Flow From Operations | 13.43 B | ||||
| Short Ratio | 1.65 X | ||||
| Earnings Per Share | 3.94 X | ||||
| Price To Earnings To Growth | 2.27 X | ||||
| Target Price | 68.35 | ||||
| Number Of Employees | 219 K | ||||
| Beta | 0.54 | ||||
| Market Capitalization | 75.45 B | ||||
| Total Asset | 249.73 B | ||||
| Retained Earnings | 61.6 B | ||||
| Working Capital | (11.33 B) | ||||
| Current Asset | 30.38 B | ||||
| Current Liabilities | 23.17 B | ||||
| Annual Yield | 0.05 % | ||||
| Five Year Return | 2.81 % | ||||
| Net Asset | 249.73 B | ||||
| Last Dividend Paid | 2.6 |
About CVS Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CVS Health Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CVS Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CVS Health Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CVS Stock Analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.